Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (1664)	6/30/2003 8:18:10 PM
From: Icebrg	Read Replies (1) of 3044

Xoma Gets $4 Million From Millennium Pharmaceuticals DOW JONES NEWSWIRES WASHINGTON -- Xoma Ltd. (XOMA) said Monday it has received $4 million from Millennium Pharmaceuticals Inc. (MLNM ) under a collaboration and investment agreement between the companies, according to a Form 8-K filed with the Securities and Exchange Commission. The company said that in return for the cash, it issued 608,766 shares to Millennium Pharmaceuticals at $6.57 a share. Xoma said that under the agreement, it keeps the option to issue up to an additional $33.5 million of its common shares to Millennium Pharmaceuticals at prevailing market prices over the next 20 months. According to the filing, Millennium Pharmaceuticals registered the new shares with the SEC for resale under a Form S-3. Xoma is a biotechnology and pharmaceutical company based in Berkeley, Calif. Millennium Pharmaceutical is a drug discovery and development company based in Cambridge, Mass. -By Gee L. Lee, Dow Jones Newswires; 202-862-1346; gee.lee@dowjones.com Updated June 30, 2003 2:23 p.m.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next